Preferred S-adenosylmethionine prescription in routine practice for intrahepatic cholestasis management: results of a multinomial logistic regression grid-optimization approach

References

• Luketic VA. Diagnosis of cholestasis. In: Lindor K, Talwalkar J, editors. Cholestatic Liver Disease. Totowa, NJ: Humana Press Inc.; 2008:1–20.
   Google Scholar
• European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51(2):237–267.
   PubMed Web of Science ®Google Scholar
• Bortolini M, Almasio P, Bray G, et al. Multicentre survey of the prevalence of intrahepatic cholestasis in 2520 consecutive patients with newly diagnosed chronic liver disease. Clin Drug Investig. 1992;4(Suppl 4):83–89.
   Google Scholar
• Sorrentino P, Tarantino G, Perrella A, Micheli P, Perrella O, Conca P. A clinical-morphological study on cholestatic presentation of nonalcoholic fatty liver disease. Dig Dis Sci. 2005;50(6):1130–1135.
   PubMed Web of Science ®Google Scholar
• Anstee QM, Day CP. S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility. J Hepatol. 2012;57(5):1097–1109.
   PubMed Web of Science ®Google Scholar
• Catalino F, Scarponi S, Cesa F, Loiacono D, Bortolini M. Efficacy and safety of intravenous S-adenosyl-L-methionine therapy in the management of intrahepatic cholestasis of pregnancy. Clin Drug Investig. 1992;4(Suppl 4):78–82.
   Google Scholar
• Frezza M, Surrenti C, Manzillo G, Fiaccadori F, Bortolini M, Di Padova C. Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study. Gastroenterology. 1990;99(1):211–215.
   Web of Science ®Google Scholar
• Hardy ML, Coulter I, Morton SC, et al. S-adenosyl-L-methionine for treatment of depression, osteoarthritis, and liver disease. Evid Rep Technol Assess (Summ). 2003;64:1–3.
   Google Scholar
• Lafuenti G, Plotti G, Nicolanti G, Gaglione R, Tibollo FG, Mancuso S. Valutazione delle modificazioni di parametri clinici e biochimici in gravide con colestasi in terapia con S-adenosyl-L-methionine per os. [Evaluation of the obstetrical risk in pregnant women with intrahepatic cholestasis treated with S-adenosyl-L-methionine]. Recenti Prog Med. 1988;79(10):420–423. Italian.
   Google Scholar
• Manzillo G, Piccinino F, Surrenti C, Frezza M, Giudici G, Le Grazie C. Multicentre double-blind placebo-controlled study of intravenous and oral S-adenosyl-L-methionine (SAMe) in cholestatic patients with liver disease. Clin Drug Investig. 1992;4(Suppl 4):90–100.
   Google Scholar
• Mato JM, Cámara J, Fernández de Paz J, et al. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol. 1999;30(6):1081–1089.
   Web of Science ®Google Scholar
• Nicastri PL, Diaferia A, Tartagni M, Loizzi P, Fanelli M. A randomised placebo-controlled trial of ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy. Br J Obstet Gynaecol. 1998;105(11):1205–1207.
   PubMedGoogle Scholar
• Qin B, Guo S, Zhao Y, et al. A trial of ademetionine in the treatment of intrahepatic biliary stasis viral hepatitis. Zhonghua Gan Zang Bing Za Zhi. 2000;8(3):158–160.
   Google Scholar
• Frezza M, Pozzato G, Chiesa L, Stramentinoli G, Di Padova C. Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-L-methionine administration. Hepatology. 1984;4(2):274–278.
   Web of Science ®Google Scholar
• Shetty K, Rybicki L, Carey WD. The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis. Hepatology. 1997;25(5):1049–1053.
   Web of Science ®Google Scholar
• Cholongitas E, Papatheodoridis GV, Vangeli M, Terreni N, Patch D, Burroughs AK. Systematic review: the model for end-stage liver disease – should it replace Child-Pugh’s classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther. 2005;22(11–12):1079–1089.
   PubMed Web of Science ®Google Scholar
• Patorno E, Grotta A, Bellocco R, Schneeweiss S. Propensity score methodology for confounding control in health care utilization databases. Epidemiol Biostat Public Health. 2013;10(3):e89401–e894016.
   Google Scholar
• Tape T. The area under an ROC curve. 2015. Available from: http://gim.unmc.edu/dxtests/ROC3.htm. Accessed May 30, 2017.
   Google Scholar
• MedlinePlus. Bilirubin blood test [webpage on the Internet]. 2013. Available from: https://medlineplus.gov/ency/article/003479.htm. Accessed May 30, 2017.
   Google Scholar
• Rassen JA, Shelat AA, Franklin JM, Glynn RJ, Solomon DH, Schneeweiss S. Matching by propensity score in cohort studies with three treatment groups. Epidemiology. 2013;24(3):401–409.
   PubMed Web of Science ®Google Scholar
• Fawcett T. An introduction to ROC analysis. Pattern Recognit Lett. 2005;27(8):861–874.
   Web of Science ®Google Scholar